A compact, low-cost optical sensor using planar waveguide interferometry to detect free and total chlorine in water. Provides fast, reversible, reagent-free measurements with ppb to ppt sensitivity. Designed for mobile, in-container analysis or in-situ monitoring with automatic data logging, suitable for water quality monitoring applications.
This solution is a miniaturized, low-cost planar waveguide-based interferometric sensor developed for detecting chlorine and other chemicals in water. The technology addresses the need for rapid, direct measurement of water quality parameters without the use of consumable reagents. By coupling a chemically selective film to the waveguide surface, the sensor enables selective detection of target analytes such as free chlorine, total chlorine, chloramines, proteins, and whole organisms. The platform is designed for flexible deployment, supporting both mobile, in-container analysis with instant results and continuous in-situ monitoring with automatic data logging and remote communication.
The sensor has been experimentally demonstrated for the detection of multiple chemicals, including free chlorine and chloramines, as well as biological targets such as proteins and whole organisms. Current and planned validation work focuses on three areas: (1) sensing film design and testing, including modification of existing chlorine-selective chemistry to enable total chlorine detection and characterization of sensitivity; (2) system re-engineering to meet customer requirements for size, power consumption, and usability; and (3) extensive laboratory testing to assess overall technology readiness. The platform is advancing toward deployment-ready configurations suitable for field and commercial use.
Georgia Institute of Technology is a large, technology‑focused public research university in Atlanta with a strong applied research culture. Industry engages through the Georgia Tech Research Institute for contract R&D, a Midtown innovation district with co‑located corporate labs, and a statewide manufacturing extension to support scale‑up. A long‑standing partnership with a major academic medical center enables clinical translation, and a large co‑op program delivers a steady talent pipeline. Research is backed by competitive federal funding from NSF, NIH, DOE, DoD, and NASA. Technology commercialization is managed by the Georgia Tech Research Corporation, with dedicated licensing, corporate contracting, and startup support.